Segment disclosures

Company overview

ANIKA THERAPEUTICS INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 4 retained observations 2 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Single Reportable Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=anik:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3032610000 USD20260729Open filing evidence
2026-01-01 – 2026-06-3062222000 USD20260729Open filing evidence
2025-04-01 – 2025-06-3028219000 USD20260729Open filing evidence
2025-01-01 – 2025-06-3054387000 USD20260729Open filing evidence